TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/6/24 12:20 | 8/5/24 | MRK | Merck & Co., Inc. | NJ | Health | Drug | Pharmaceutical Preparations | Guindo Chirfi | NJ | O | CMO | M.d | 4,251 | 115.20 | 0 | 37 | 999% | 40 | D | ||||||||||||||
8/4/23 16:17 | 8/3/23 | MRK | Merck & Co., Inc. | NJ | Health | Drug | Pharmaceutical Preparations | Guindo Chirfi | NJ | O | CMO | M.d | 3,900 | 105.70 | 0 | 37 | 20 | D | |||||||||||||||
2/23/22 16:15 | 2/18/22 | BIIB | Biogen Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Guindo Chirfi | MA | O | Head of | M.d | 0 | 0.00 | 0 | 2 | 37 | 7 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |